Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cyberonics and Italy’s Sorin Group Inch Closer to a Finished Deal - Medical Product Outsourcing
Columns

Cyberonics and Italy’s Sorin Group Inch Closer to a Finished Deal

Cyberonics Inc. and Sorin S.p.A., which announced a merger in February, are making progress on regulatory fronts.

The companies’ registration statement on Form S-4 for LivaNova plc, the proposed name for the newly formed company, filed in April and amended three times, was declared effective by the U.S. Securities and Exchange Commission, thus paving the way for convening the special meeting of Cyberonics stockholders to consider and vote on the transaction. The meeting will take place on Sept. 22.

The companies currently expect that the merger, which remains subject to Cyberonics stockholder approval and satisfaction of other customary closing conditions, will close in the fourth calendar quarter of 2015.

Cyberonics’ core expertise is in neuromodulation technology. The company makes the VNS Therapy system, which is U.S. Food and Drug Administration-approved for the treatment of medically refractory epilepsy and treatment-resistant depression. The company is based in Houston, Texas.

Sorin makes medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders. The company’s headquarters are in Milan, Italy. 

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters